SNNAQ — Sienna Biopharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$11.33m
Annual cashflow statement for Sienna Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -11.3 | -21.2 | -50.5 | -73.5 |
| Depreciation | ||||
| Non-Cash Items | 1.2 | 0.981 | 7.89 | 8.46 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.088 | 2.43 | 1.45 | 3.17 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Cash from Operating Activities | -9.98 | -17.7 | -41.1 | -61.7 |
| Capital Expenditures | -0.088 | -0.238 | -0.274 | -0.039 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | -6.82 | 0.008 | 0 |
| Acquisition of Business | ||||
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | -0.088 | -7.06 | -0.266 | -0.039 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 14.6 | 28.8 | 107 | 36 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 4.55 | 4.13 | 65.4 | -25.9 |